| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.05 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.037 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |